Moving xenotransplantation research into human trials will require adjusting our expectations, researchers say
On the heels of some important “firsts” this past year, xenotransplantation — grafting animal organs…
Category: Breakthrough22
STAT+: Mark Cuban’s company is building a ‘parallel supply chain’ for prescription drugs
Mark Cuban’s drug company started with an ambitious premise: to circumvent middlemen to offer cheaper…
‘Skinny, greasy mice,’ artificial cells and tumor mapping: Researchers vie for STAT Madness championship
Were the oily rodents impressive enough? More amazing than the family tree of tumors? Than…
Califf admits the FDA’s Alzheimer’s drug decision impacted experts’ trust in the agency
WASHINGTON — Robert Califf, the new head of the Food and Drug Administration, admitted Thursday…
In the wake of big patent decision, it’s business as usual for CRISPR therapy developers
Earlier this month, the U.S. Patent and Trademark Office ruled that CRISPR patents key to…